InvestorsHub Logo

Its_lose_not_loose

06/16/21 1:38 PM

#145372 RE: Nanotoday #145369

Kinda like that, yeah.

KMBJN

06/16/21 10:52 PM

#145373 RE: Nanotoday #145369

There is no argument about the use of the word drug, only stating of the industry standard.

All biotech companies and clinical trials refer to non-FDA approved compounds intended to treat or prevent illness as drugs.

This is a fact.

There really is nothing to argue.

I could give thousands of examples of non-FDA approved investigational compounds being called drugs.

Here's one:

https://www.bloomberg.com/news/articles/2021-05-13/alzheimer-s-drug-biogen-hopes-controversial-aducanumab-gets-fda-approval

NNVC's any my use of the word drug for the nanoviricide compounds NNVC is developing is consistent with industry standards.

Arguing otherwise is just silly and wrong, although my stating the obvious sadly will not stop any of the continuing silliness and ignorant punditry.

Here, take it from the FDA about investigational drugs. How could anyone believe or argue otherwise?

https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-investigational-drugs

Yes, even preclinical compounds are called "drugs!"

https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-S1-S2

The basics of preclinical drug development for neurodegenerative disease indications



Here is the FDA:

https://www.fda.gov/patients/drug-development-process/step-2-preclinical-research

Before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity.



I believe a phrase such as "my word" or equivalent is appropriate to express the level of disbelief for any argument against the use of the word drug for investigational compounds.

Truly unbelievable that anyone thinks that the compounds NNVC is developing should not be called drugs.